| European Case Law Identifier: | ECLI:EP:BA:2013:T065711.20131108 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 08 November 2013 | ||||||||
| Case number: | T 0657/11 | ||||||||
| Application number: | 05747848.9 | ||||||||
| IPC class: | A23L 1/325 A23J 3/30 A23J 3/32 A23J 3/34 A23J 1/04 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Hydrolysed marine protein product, process for the production thereof, and application | ||||||||
| Applicant name: | Norcape Biotechnology AS | ||||||||
| Opponent name: | BASF Personal Care and Nutrition GmbH | ||||||||
| Board: | 3.3.09 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Correction of error - yes Sufficiency - yes Remittal for further prosecution |
||||||||
| Catchwords: |
In opposition proceedings mistakes or errors concerning the claims, the description or the drawings of the patent as granted may be removed either by an amendment occasioned by a ground of opposition under Article 100 EPC or, as far as the mistakes or errors concern texts or drawings which remain unamended, by way of a correction pursuant to Rule 139 EPC (see point 3 of the Reasons). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t110657eu1.html
Date retrieved: 17 May 2021
15 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
EPC Implementing Rules
EPO Guidelines - H Amendments and Corrections
Case Law Book: II Conditions to be met by an Application
XCLR II E 4.2.3 Obvious correction – immediately evident that nothing else would have been intended than what is offered as the correction
XCLR II E 4.3 Correction of errors in the description, claims and drawings after grant, and in opposition proceedings